Inventors:
Rothstein L. Thomas - Port Washington NY, US
Daniel O. Griffin - Port Washington NY, US
Nichol E. Holodick - Roslyn Heights NY, US
International Classification:
C12N 5/0781
A61K 39/395
G01N 33/68
US Classification:
4241731, 4353431, 435 792, 5303896, 435 612
Abstract:
The present invention is directed to isolated populations of human natural immunoglobulin-producing B1 lymphocytes, wherein the B1 lymphocytes display surface biomarkers CD20, CD43 and CD27 and are either CD11b+ or GD11b−. The present invention is also directed to a method of isolating human natural immunoglobulin-producing B1 lymphocytes from a blood sample comprising isolating B lymphocytes from the sample that express surface biomarkers CD20, CD43 and CD27, and, optionally, CD11b. In addition, the present invention is directed to a methods for diagnosing a B1 cell disorder in a patient, determining the prognosis of a patient having a B1 cell disorder, and treating a patient having a B1 cell disorder.